EJECTION FRACTION DECREASED side effect
What is EJECTION FRACTION DECREASED ?
Help Community - Describe Your Side Effect
Search FDA Side Effects
Ask Health Expert
EJECTION FRACTION DECREASED and Recently Reported Side Effects
EJECTION FRACTION DECREASED and 15 most Active Side Effect polls
EJECTION FRACTION DECREASED and featured health surveys
Substances toxic to Health
Recent Hospital reviews
Comments about Side Effects
Hospital Quality reviews
Homecare Quality reviews
Drugs associated with EJECTION FRACTION DECREASED
ABRAXANE ADRIAMYCIN AGGRASTAT ALIMTA AMLODIPINE ANGIOMAX ARGATROBAN ARIMIDEX ASPIRIN AVANDIA AVASTIN AVONEX BEXTRA BUPROPION BYETTA CAPECITABINE CARBOPLATIN CARDENSIEL CARVEDILOL CELEBREX CELESTONE CETUXIMAB CGS CILOSTAZOL CISPLATIN CITALOPRAM CLOLAR COREG CORTISONE CUBICIN CYCLOPHOSPHAMIDE CYMBALTA CYTARABINE DACOGEN DAUNORUBICIN DESFERAL DIGOXIN DILTIAZEM DIOVAN DOXIL ERLOTINIB ESCITALOPRAM FEMARA FLUDARABINE FLUOROURACIL FORTEO FUROSEMIDE GLEEVEC HEPARIN HERCEPTIN HYDROXYCHLOROQUI IMATINIB INFLIXIMAB JANUVIA LAPATINIB LETROZOLE LIALDA LIORESAL LIPITOR LYRICA MABTHERA METHERGINE METHOTREXATE METOPROLOL MIMPARA MITOXANTRONE MYCOPHENOLATE NADOLOL NATALIZUMAB NATRECOR NATULAN NEXAVAR NOVANTRONE NUTROPIN ONDANSETRON PACLITAXEL PAZOPANIB PERMAX PLAVIX PREMARIN REBIF REDUX REMICADE REVLIMID RITUXAN RITUXIMAB SIROLIMUS STI SUNITINIB SUTENT TARCEVA TASIGNA TAXOL TAXOTERE TEMSIROLIMUS THALIDOMIDE TOFRANIL TORISEL TRACLEER TRASTUZUMAB TRETINOIN TYKERB TYVERB VELCADE VERAPAMIL VFEND VYTORIN XIFAXAN XYLOCAINE ZELNORM ZOLINZA ZYPREXAPazopanib Side Effects Report #5651021-2
Physician from SINGAPORE reported PAZOPANIB problem on Feb 28, 2008. Female patient, 47 years of age, weighting 96.78 lb, was diagnosed with breast cancer metastatic and was treated with PAZOPANIB. After drug was administered, patient experienced the following problems/side effects: ejection fraction decreased, . PAZOPANIB dosage: 800MG PER DAY. During the same period patient was treated with LAPATINIB. Patient recovered.
Herceptin Side Effects Report #5655837-8
HERCEPTIN problem was reported by a Physician from UNITED KINGDOM on Feb 25, 2008. Female patient, 32 years of age, was diagnosed with breast cancer and was treated with HERCEPTIN. After drug was administered, patient experienced the following problems/side effects: ejection fraction decreased, hyperthyroidism, . HERCEPTIN dosage: unknown. Patient recovered.
Novantrone Side Effects Report #5664144-9
Consumer or non-health professional from UNITED STATES reported NOVANTRONE problem on Feb 25, 2008. Female patient, 50 years of age, was diagnosed with off label use, multiple sclerosis and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: ejection fraction decreased, fatigue, . NOVANTRONE dosage: unknown. During the same period patient was treated with REBIF, PROVIGIL, ZOLOFT, LEVOTHYROXINE, OMACOR, NEXIUM, BACLOFEN, DETROL LA. Patient recovered.
Imatinib Side Effects Report #5672292-2
IMATINIB problem was reported by a Health Professional from ITALY on Mar 11, 2008. Male patient, 62 years of age, was diagnosed with chronic myeloid leukaemia and was treated with IMATINIB. After drug was administered, patient experienced the following problems/side effects: ejection fraction decreased, mitral valve replacement, myocardial infarction, . IMATINIB dosage: 400 MG/D. Patient recovered.
Novantrone Side Effects Report #5677905-7
Consumer or non-health professional from UNITED STATES reported NOVANTRONE problem on Mar 05, 2008. Male patient, 65 years of age, was diagnosed with multiple sclerosis and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: ejection fraction decreased, . NOVANTRONE dosage: 10 MG/M2, 1 IN 1 MONTHS, INTRAVENOUS. Patient recovered.
Tracleer Side Effects Report #5683449-9
TRACLEER problem was reported by a Consumer or non-health professional from AUSTRIA on Mar 13, 2008. Male patient, 76 years of age, was diagnosed with pulmonary hypertension and was treated with TRACLEER. After drug was administered, patient experienced the following problems/side effects: ejection fraction decreased, tricuspid valve incompetence, . TRACLEER dosage: 62.5 MG, BID, ORAL. During the same period patient was treated with CONCOR, DIGIMERICK, LASIX, MIXTARD, VALSARTAN AND HYDROCHLOROTHIAZIDE, NOVALGIN, MOLSIDOLAT. Patient died on 09/01/2007.
Lyrica Side Effects Report #5689491-6
Physician from BELGIUM reported LYRICA problem on Mar 19, 2008. Male patient, 35 years of age, was diagnosed with neuralgia and was treated with LYRICA. After drug was administered, patient experienced the following problems/side effects: ejection fraction decreased, oedema peripheral, . LYRICA dosage: DAILY DOSE:300MG. During the same period patient was treated with CANRENOL, COVERSYL, SINTROM, DURAGESIC. Patient recovered.
Dacogen Side Effects Report #5623182-2
DACOGEN problem was reported by a Physician from UNITED STATES on Jan 30, 2008. Male patient, weighting 184.0 lb, was diagnosed with acute myeloid leukaemia and was treated with DACOGEN. After drug was administered, patient experienced the following problems/side effects: ejection fraction decreased, . DACOGEN dosage: 40 MG, 1 IN 5 DAY, INTRAVENOUS. During the same period patient was treated with VALPROIC ACID, FOLIC ACID, ZOLOFT, MEGACE, ADVAIR DISKUS, PROCRIT, CARAFATE, ZOCOR. Patient recovered.
Capecitabine Side Effects Report #5629962-1
Physician from KOREA, REPUBLIC OF reported CAPECITABINE problem on Feb 11, 2008. Male patient, 56 years of age, weighting 119.7 lb, was diagnosed with gastric cancer and was treated with CAPECITABINE. After drug was administered, patient experienced the following problems/side effects: ejection fraction decreased, . CAPECITABINE dosage: unknown. During the same period patient was treated with TRASTUZUMAB, CISPLATIN. Patient was hospitalized. Patient recovered.
Forteo Side Effects Report #5635123-2
FORTEO problem was reported by a Physician from UNITED STATES on Feb 11, 2008. Female patient was diagnosed with osteoporosis, cardiomyopathy and was treated with FORTEO. After drug was administered, patient experienced the following problems/side effects: ejection fraction decreased, feeling abnormal, injection site bruising, injection site erythema, injection site pain, loss of consciousness, nausea, viral infection, . FORTEO dosage: unknown. During the same period patient was treated with SIMVASTATIN, PRILOSEC, ATACAND. Patient recovered.
Ondansetron Side Effects Report #5635649-1
Consumer or non-health professional from FRANCE reported ONDANSETRON HYDROCHLORIDE problem on Feb 05, 2008. Female patient, 47 years of age, was diagnosed with nausea and was treated with ONDANSETRON HYDROCHLORIDE. After drug was administered, patient experienced the following problems/side effects: ejection fraction decreased, myocardial ischaemia, pericardial effusion, . ONDANSETRON HYDROCHLORIDE dosage: 4 MG / SINGLE DOSE / INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE. Patient recovered.
Escitalopram Side Effects Report #5636177-X
ESCITALOPRAM problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 05, 2008. Female patient was treated with ESCITALOPRAM. After drug was administered, patient experienced the following problems/side effects: ejection fraction decreased, overdose, . ESCITALOPRAM dosage: 40 MG QD PO. During the same period patient was treated with AMITRIPTYLINE. Patient recovered.
Dacogen Side Effects Report #5642212-5
Physician from UNITED STATES reported DACOGEN problem on Feb 14, 2008. Male patient, weighting 184.0 lb, was diagnosed with acute myeloid leukaemia and was treated with DACOGEN. After drug was administered, patient experienced the following problems/side effects: ejection fraction decreased, . DACOGEN dosage: 40 MG, 1 IN 5 DAY, INTRAVENOUS; 4TH CYCLE. During the same period patient was treated with ZOLOFT, PROCRIT, ZOCOR. Patient recovered.
Taxol Side Effects Report #5645503-7
TAXOL problem was reported by a Consumer or non-health professional from UNITED STATES on June 06, 2007. Male patient, 55 years of age, was diagnosed with adenocarcinoma and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: ejection fraction decreased, . TAXOL dosage: unknown. During the same period patient was treated with CARBOPLATIN, FAMOTIDINE, DIPHENHYDRAMINE, APREPITANT, ONDANSETRON, DEXAMETHASONE, PERCOCET. Patient was hospitalized and became disabled. Patient recovered.
Dacogen Side Effects Report #5587678-4
Physician from UNITED STATES reported DACOGEN problem on Dec 19, 2007. Female patient was treated with DACOGEN. After drug was administered, patient experienced the following problems/side effects: ejection fraction decreased, . DACOGEN dosage: unknown. Patient recovered.
Nutropin Side Effects Report #5590673-2
NUTROPIN problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 11, 2008. Female patient, 25 years of age, was diagnosed with growth hormone deficiency and was treated with NUTROPIN. After drug was administered, patient experienced the following problems/side effects: ejection fraction decreased, . NUTROPIN dosage: unknown. Patient recovered.
Pazopanib Side Effects Report #5593293-9
Physician from SINGAPORE reported PAZOPANIB problem on Jan 08, 2008. Female patient, 47 years of age, weighting 96.78 lb, was treated with PAZOPANIB. After drug was administered, patient experienced the following problems/side effects: ejection fraction decreased, . PAZOPANIB dosage: 800MG PER DAY. During the same period patient was treated with LAPATINIB. Patient recovered.
Capecitabine Side Effects Report #5609375-9
CAPECITABINE problem was reported by a Physician from KOREA, REPUBLIC OF on Jan 25, 2008. Male patient, 56 years of age, weighting 119.7 lb, was diagnosed with gastric cancer and was treated with CAPECITABINE. After drug was administered, patient experienced the following problems/side effects: ejection fraction decreased, . CAPECITABINE dosage: unknown. During the same period patient was treated with TRASTUZUMAB, CISPLATIN. Patient was hospitalized. Patient recovered.
Lialda Side Effects Report #5610930-0
Physician from UNITED STATES reported LIALDA problem on Jan 10, 2008. Male patient, 24 years of age, weighting 276.0 lb, was diagnosed with colitis ulcerative and was treated with LIALDA. After drug was administered, patient experienced the following problems/side effects: ejection fraction decreased, myocarditis, . LIALDA dosage: unknown. Patient was hospitalized. Patient recovered.
Avastin Side Effects Report #5537254-4
AVASTIN problem was reported by a Physician from UNITED STATES on Nov 29, 2007. Female patient was diagnosed with breast cancer and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: ejection fraction decreased, . AVASTIN dosage: unknown. During the same period patient was treated with ABRAXANE. Patient recovered.
Abraxane Side Effects Report #5553432-2
Physician from UNITED STATES reported ABRAXANE problem on Nov 27, 2007. Female patient was diagnosed with breast cancer metastatic and was treated with ABRAXANE. After drug was administered, patient experienced the following problems/side effects: ejection fraction decreased, tachycardia, . ABRAXANE dosage: unknown. During the same period patient was treated with AVASTIN. Patient was hospitalized. Patient recovered.
Pazopanib Side Effects Report #5571738-8
PAZOPANIB problem was reported by a Physician from SINGAPORE on Dec 19, 2007. Female patient, 47 years of age, weighting 96.78 lb, was treated with PAZOPANIB. After drug was administered, patient experienced the following problems/side effects: ejection fraction decreased, . PAZOPANIB dosage: 800MG PER DAY. During the same period patient was treated with LAPATINIB. Patient recovered.
Byetta Side Effects Report #5506751-X
Physician from UNITED STATES reported BYETTA problem on Oct 29, 2007. Male patient, 73 years of age, was treated with BYETTA. After drug was administered, patient experienced the following problems/side effects: ejection fraction decreased, electrocardiogram st segment depression, electrocardiogram t wave inversion, hepatotoxicity, . BYETTA dosage: unknown. During the same period patient was treated with LISINOPRIL, IMDUR, NEXIUM, ASPIRIN, COREG, PLAVIX, GLIPIZIDE, LASIX. Patient was hospitalized. Patient recovered.
Novantrone Side Effects Report #5510678-7
NOVANTRONE problem was reported by a Physician from UNITED STATES on Oct 23, 2007. Male patient, 37 years of age, weighting 192.0 lb, was diagnosed with multiple sclerosis and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: ejection fraction decreased, . NOVANTRONE dosage: 12 MG/M2, ONCE, INTRAVENOUS (NOT OTHERWISE SPECIFIED); 5 MG/M2, INTRAVENOUS (NOT OTHERWISE SPECIFIED. Patient recovered.
Novantrone Side Effects Report #5522930-X
Physician from UNITED STATES reported NOVANTRONE problem on Nov 05, 2007. Male patient, 51 years of age, was diagnosed with multiple sclerosis and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: ejection fraction decreased, . NOVANTRONE dosage: 20.7 MG/M2, 1 IN 3 MONTHS, INTRAVENOUS (NOT OTHERWISE SPECIFIED). Patient recovered.
Rebif Side Effects Report #5525774-8
REBIF problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 09, 2007. Female patient, 50 years of age, was diagnosed with multiple sclerosis and was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: ejection fraction decreased, . REBIF dosage: 44 MG, 3 IN 1 WEEKS, SUBCUTANEOUS. Patient recovered.
Byetta Side Effects Report #5527740-5
Physician from UNITED STATES reported BYETTA problem on Nov 19, 2007. Male patient, 73 years of age, was treated with BYETTA. After drug was administered, patient experienced the following problems/side effects: ejection fraction decreased, electrocardiogram st segment depression, electrocardiogram t wave inversion, hepatotoxicity, . BYETTA dosage: unknown. During the same period patient was treated with LISINOPRIL, IMDUR, NEXIUM, ASPIRIN, COREG, PLAVIX, GLIPIZIDE, LASIX. Patient was hospitalized. Patient recovered.
Novantrone Side Effects Report #5481135-1
NOVANTRONE problem was reported by a Physician from UNITED STATES on Sept 21, 2007. Female patient, 29 years of age, weighting 282.0 lb, was diagnosed with multiple sclerosis and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: ejection fraction decreased, . NOVANTRONE dosage: unknown. Patient recovered.
Novantrone Side Effects Report #5483102-0
Consumer or non-health professional from UNITED STATES reported NOVANTRONE problem on Sept 28, 2007. Male patient, 37 years of age, weighting 175.0 lb, was diagnosed with multiple sclerosis and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: ejection fraction decreased, . NOVANTRONE dosage: unknown. Patient recovered.
Imatinib Side Effects Report #5483297-9
IMATINIB problem was reported by a Health Professional from ITALY on Oct 04, 2007. Male patient, 62 years of age, was diagnosed with chronic myeloid leukaemia and was treated with IMATINIB. After drug was administered, patient experienced the following problems/side effects: ejection fraction decreased, mitral valve replacement, myocardial infarction, . IMATINIB dosage: 400 MG/D. Patient recovered.
Novantrone Side Effects Report #5489164-9
Physician from UNITED STATES reported NOVANTRONE problem on Oct 04, 2007. Male patient, 37 years of age, weighting 175.0 lb, was diagnosed with multiple sclerosis and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: ejection fraction decreased, . NOVANTRONE dosage: unknown. Patient recovered.
Novantrone Side Effects Report #5493080-6
NOVANTRONE problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 12, 2007. Male patient, 63 years of age, was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: ejection fraction decreased, . NOVANTRONE dosage: unknown. Patient died.
Aggrastat Side Effects Report #5494549-0
Physician from ITALY reported AGGRASTAT problem on Oct 15, 2007. Female patient, 78 years of age, weighting 216.1 lb, was diagnosed with cardiac enzymes increased, electrocardiogram st segment depression and was treated with AGGRASTAT. After drug was administered, patient experienced the following problems/side effects: ejection fraction decreased, troponin t increased, . AGGRASTAT dosage: unknown. During the same period patient was treated with ASPIRIN, CLOPIDOGREL BISULPHATE, HEPARIN, INSULIN. Patient died on 10/01/2007.
Byetta Side Effects Report #5499565-0
BYETTA problem was reported by a Physician from UNITED STATES on Oct 17, 2007. Male patient, 73 years of age, was treated with BYETTA. After drug was administered, patient experienced the following problems/side effects: ejection fraction decreased, electrocardiogram st segment depression, electrocardiogram t wave inversion, hepatotoxicity, . BYETTA dosage: unknown. During the same period patient was treated with LISINOPRIL, IMDUR, NEXIUM, ASPIRIN, COREG, PLAVIX, GLIPIZIDE, LASIX. Patient was hospitalized. Patient recovered.
Herceptin Side Effects Report #5502308-5
Physician from UNITED KINGDOM reported HERCEPTIN problem on Oct 15, 2007. Female patient, 55 years of age, was diagnosed with breast cancer and was treated with HERCEPTIN. After drug was administered, patient experienced the following problems/side effects: ejection fraction decreased, electrocardiogram abnormal, hypertension, . HERCEPTIN dosage: unknown. Patient was hospitalized. Patient recovered.
Novantrone Side Effects Report #5450662-5
NOVANTRONE problem was reported by a Physician from UNITED STATES on Aug 29, 2007. Female patient, 47 years of age, weighting 110.0 lb, was diagnosed with multiple sclerosis and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: ejection fraction decreased, oedema peripheral, . NOVANTRONE dosage: 20 MG, 1 IN 3 MONTHS, INTRAVENOUS (NOT OTHERWISE SPECIFIED). During the same period patient was treated with PREDNISONE, CLONAZEPAM. Patient recovered.
Pazopanib Side Effects Report #5453810-6
Physician from PAKISTAN reported PAZOPANIB problem on Sept 14, 2007. Female patient, 63 years of age, weighting 132.3 lb, was treated with PAZOPANIB. After drug was administered, patient experienced the following problems/side effects: ejection fraction decreased, . PAZOPANIB dosage: 400MG PER DAY. During the same period patient was treated with LAPATINIB. Patient recovered.
Clolar Side Effects Report #5455752-9
CLOLAR problem was reported by a Pharmacist from UNITED STATES on Sept 13, 2007. Female patient, child 10 years of age, weighting 74.96 lb, was diagnosed with acute lymphocytic leukaemia, disease recurrence and was treated with CLOLAR. After drug was administered, patient experienced the following problems/side effects: ejection fraction decreased, gallop rhythm present, ventricular dysfunction, . CLOLAR dosage: 57MG/DAILY/IV. During the same period patient was treated with HYDROCORTISONE, ONDANSETRON, VORICONAZOLE, ALLOPURINOL, ACYCLOVIR, BACTRIM, CETIRIZINE. Patient recovered.
Nutropin Side Effects Report #5409568-X
Consumer or non-health professional from UNITED STATES reported NUTROPIN problem on Aug 03, 2007. Female patient, 25 years of age, was diagnosed with growth hormone deficiency and was treated with NUTROPIN. After drug was administered, patient experienced the following problems/side effects: ejection fraction decreased, . NUTROPIN dosage: unknown. Patient recovered.
Novantrone Side Effects Report #5410245-X
NOVANTRONE problem was reported by a Physician from UNITED STATES on July 26, 2007. Male patient, 51 years of age, was diagnosed with multiple sclerosis and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: ejection fraction decreased, . NOVANTRONE dosage: 20.7 MG/M2, 1 IN 3 MONTHS, INTRAVENOUS (NOT OTHERWISE SPECIFIED). Patient recovered.
Letrozole Side Effects Report #5411774-5
Physician from UNITED KINGDOM reported LETROZOLE problem on July 31, 2007. Female patient, 64 years of age, was diagnosed with breast cancer metastatic and was treated with LETROZOLE. After drug was administered, patient experienced the following problems/side effects: ejection fraction decreased, . LETROZOLE dosage: 2.5 MG, QD. Patient recovered.
Mitoxantrone Side Effects Report #5427706-X
MITOXANTRONE problem was reported by a Consumer or non-health professional from GERMANY on Aug 15, 2007. Male patient, 58 years of age, was diagnosed with encephalitis and was treated with MITOXANTRONE. After drug was administered, patient experienced the following problems/side effects: ejection fraction decreased, endocardial fibrosis, ventricular hypokinesia, . MITOXANTRONE dosage: 23 MG, 3 CYCLE, INTRAVENOUS (NOT OTHERWISE SPECIFIED). Patient recovered.
Nutropin Side Effects Report #5429650-0
Consumer or non-health professional from UNITED STATES reported NUTROPIN problem on Aug 21, 2007. Female patient, 25 years of age, was diagnosed with growth hormone deficiency and was treated with NUTROPIN. After drug was administered, patient experienced the following problems/side effects: ejection fraction decreased, . NUTROPIN dosage: unknown. Patient recovered.
Novantrone Side Effects Report #5430380-X
NOVANTRONE problem was reported by a Physician from UNITED STATES on Aug 15, 2007. Female patient, 29 years of age, weighting 282.0 lb, was diagnosed with multiple sclerosis and was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: ejection fraction decreased, . NOVANTRONE dosage: unknown. Patient recovered.
Lapatinib Side Effects Report #5377388-0
Physician from IRELAND reported LAPATINIB problem on July 02, 2007. Female patient, 42 years of age, weighting 148.2 lb, was treated with LAPATINIB. After drug was administered, patient experienced the following problems/side effects: ejection fraction decreased, . LAPATINIB dosage: 500MG PER DAY. During the same period patient was treated with DOCETAXEL, TRASTUZUMAB, OXYNORM, NEURONTIN, ZOLPIDEM TARTRATE, CITALOPRAM HYDROBROMIDE. Patient recovered.
Lapatinib Side Effects Report #5378693-4
LAPATINIB problem was reported by a Physician from UNITED STATES on July 02, 2007. Female patient, 81 years of age, weighting 123.2 lb, was diagnosed with hypertension, osteoporosis, neuropathy and was treated with LAPATINIB. After drug was administered, patient experienced the following problems/side effects: ejection fraction decreased, haematemesis, myocardial infarction, rhabdomyolysis, . LAPATINIB dosage: 1500MG PER DAY. During the same period patient was treated with LETROZOLE, DIOVAN, TOPROL, LASIX, ACTONEL, CALCIUM WITH VITAMIN D, LYRICA. Patient recovered.
Mitoxantrone Side Effects Report #5382147-9
Health Professional from GERMANY reported MITOXANTRONE problem on June 19, 2007. Female patient was treated with MITOXANTRONE. After drug was administered, patient experienced the following problems/side effects: ejection fraction decreased, endocardial fibrosis, ventricular hypokinesia, . MITOXANTRONE dosage: 23 MG, 3 CYCLE, IV (NOT OTHERWISE SPECIFIED). Patient recovered.
Avastin Side Effects Report #5382380-6
AVASTIN problem was reported by a Physician from UNITED KINGDOM on June 22, 2007. Female patient, weighting 141.1 lb, was diagnosed with breast cancer and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: ejection fraction decreased, pleural effusion, . AVASTIN dosage: 10 MG/KG, UNK. During the same period patient was treated with TAXOL. Patient was hospitalized. Patient recovered.
Hydroxychloroqui Side Effects Report #5383284-5
Health Professional from HONG KONG reported HYDROXYCHLOROQUINE SULPHATE problem on July 04, 2007. Female patient, 28 years of age, was diagnosed with systemic lupus erythematosus and was treated with HYDROXYCHLOROQUINE SULPHATE. After drug was administered, patient experienced the following problems/side effects: ejection fraction decreased, electromechanical dissociation, glasgow coma scale abnormal, hypokalaemia, hypotension, intentional overdose, . HYDROXYCHLOROQUINE SULPHATE dosage: unknown. Patient was hospitalized. Patient died on 08/01/2006.
Velcade Side Effects Report #5384287-7
VELCADE problem was reported by a Pharmacist from UNITED STATES on July 03, 2006. Male patient, 45 years of age, weighting 207.2 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: ejection fraction decreased, pleural effusion, . VELCADE dosage: 2.60 MG, IV BOLUS. During the same period patient was treated with FUROSEMIDE. Patient was hospitalized. Patient recovered.
Mitoxantrone Side Effects Report #5388462-7
Consumer or non-health professional from UNITED STATES reported MITOXANTRONE problem on June 29, 2007. Female patient was treated with MITOXANTRONE. After drug was administered, patient experienced the following problems/side effects: ejection fraction decreased, endocardial fibrosis, ventricular hypokinesia, . MITOXANTRONE dosage: 23 MG, 3 CYCLE, INTRAVENOUS (NOT OTHERWISE SPECIFIED). Patient recovered.